PEOPLE
Experience you can rely on. At Navin Molecular, our team combine leadership qualities, extensive industry expertise and detailed scientific and manufacturing understanding to help solve your challenges.
Senior Leadership
Dr. Vijay
Kaiwar
CEO
- CDMO

Dr. Vijay Kaiwar
CEO – CDMO
Dr. Vijay Kaiwar is the CEO of the CDMO business at Navin Molecular, where he is responsible for leading strategy, operations, and growth of the company’s Contract Development and Manufacturing Organization. Based at Dewas, he drives the expansion of capabilities, customer partnerships, and technology platforms to strengthen Navin Molecular position as a trusted global partner in life sciences.
With over 30 years of experience in the CDMO and API sectors, Dr. Kaiwar brings deep expertise in R&D, technology transfer, manufacturing, operations, and commercial management. His knowledge spans advanced technologies including small and large molecules, HPAPIs, ADCs, peptides, oligonucleotides, fermentation, and probiotics, along with a strong track record of building global partnerships with leading pharmaceutical and biotech companies.
Commercial
Ajay
Ohri
Head,
BD US

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience.
His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships.
It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.
Commercial
Dr Matthew
Stent
Head, BD Europe
& Key Accounts

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts.
He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023.
Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.
Senior Leadership
Dr. Vijay
Kaiwar
CEO –
CDMO

Dr. Vijay Kaiwar
CEO – CDMO
Dr. Vijay Kaiwar is the CEO of the CDMO business at Navin Molecular, where he is responsible for leading strategy, operations, and growth of the company’s Contract Development and Manufacturing Organization. Based at Dewas, he drives the expansion of capabilities, customer partnerships, and technology platforms to strengthen Navin Molecular position as a trusted global partner in life sciences.
With over 30 years of experience in the CDMO and API sectors, Dr. Kaiwar brings deep expertise in R&D, technology transfer, manufacturing, operations, and commercial management. His knowledge spans advanced technologies including small and large molecules, HPAPIs, ADCs, peptides, oligonucleotides, fermentation, and probiotics, along with a strong track record of building global partnerships with leading pharmaceutical and biotech companies.
Commercial
Ajay
Ohri
Head,
BD US

Ajay Ohri
Head, BD US
Ajay is a senior executive in the biopharma and chemical space with over 30 years’ of experience.
His industry prowess from holding global positions, managing business development teams and operations that have propagated strong international relationships.
It has enabled him to build unique business strategies with a customer centric focus driving R&D initiatives, establishing brands & commercial supply management in the biopharma and chemical space.
Commercial
Dr Matthew
Stent
Head, BD Europe
& Key Accounts

Dr Matthew Stent
Head, BD Europe & Key Accounts
Matthew heads-up our European business development team and is responsible for strategic key accounts.
He joined Navin in 2015 and set up the project management function, building an international team to manage both pre-sales (RFP evaluation and quoting) and project delivery coordination (technical oversight and customer communication), and transitioned into his current commercial role in early 2023.
Matthew is a synthetic organic chemist by training: he has a DPhil from the University of Oxford, UK, completed a Post-Doc at the University of Texas, USA, and has more than 15 years’ experience in techno-commercial roles in customer facing positions.
